Cabiguin, Anjelo G.
HRN: 08-25-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/30/2023
CEFUROXIME 500MG (TAB)
01/30/2023
02/06/2023
PO
500mg
Q12
S/P NSVD; Thinly MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes